EGFR and neoplasm: Finally, employing computational molecular docking studies, the authors showed that the new compounds have strong interaction with EGFR (epidermal growth factor receptor), an enzyme with tyrosine kinase domains, which is crucial for the development of non-small cell lung cancer (NSCLC) tumor cells.